Indivior Pharmaceuticals (INDV) Earnings Analysis

Indivior Pharmaceuticals (INDV) next reports earnings on 2026-07-30, consensus EPS 0.889 USD. Last quarter (2026-04-30) it beat with EPS 0.96 USD vs 0.64 USD est (+50%). It has beaten estimates in 8/8 recent quarters (100%). Trailing P/E 20.12.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does INDV next report earnings?

Next earnings date2026-07-30
Consensus EPS estimate0.889 USD
Revenue estimate0.31B

INDV earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-04-300.96 USD0.64 USD+50%Beat
2026-02-260.82 USD0.65 USD+26.2%Beat
2025-10-300.72 USD0.38 USD+89.5%Beat
2025-07-310.51 USD0.26 USD+96.2%Beat
2025-04-240.41 USD0.22 USD+86.4%Beat
2025-02-200.32 USD0.32 USD0%Beat
2024-10-240.54 USD0.31 USD+74.2%Beat
2024-07-250.44 USD0.4 USD+10%Beat

Beat rate: 8/8 (100%) over reported quarters with consensus data.

INDV valuation and analyst view

Trailing P/E20.12
Trailing EPS2.002 USD
Price / book-35.21
Dividend yield0.00%
Market cap5.00B
Analyst consensusBuy (3 buy / 0 hold / 0 sell)
Avg price target46 USD

Related research pages

Frequently asked questions

When is Indivior Pharmaceuticals (INDV)'s next earnings date?

Indivior Pharmaceuticals is next scheduled to report on 2026-07-30, with a consensus EPS estimate of 0.889 USD and revenue estimate of 0.31B.

Did INDV beat earnings last quarter?

In its 2026-04-30 report, INDV posted EPS of 0.96 USD versus a 0.64 USD estimate — a beat of 50%.

What is INDV's earnings track record?

Over the last 8 reported quarters with consensus data, INDV beat estimates 8 times (100%).

What is INDV's current P/E ratio and EPS?

INDV trades at a trailing P/E of 20.12 on trailing EPS of 2.0023613424596336 USD.

What do analysts rate INDV?

Analyst consensus is "Buy" across 3 ratings (0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell). Average 12-month price target: 46 USD.